CareDx, Inc Q4 2025 Earnings Call Summary

Testing services growth of 23% was driven by a layering effect of kidney centers restarting surveillance protocols and expanded for-cause utilization. The solution selling strategy successfully integrated digital and pharmacy offerings, resulting in 47% year-over-year growth for Patient and Digital Solutions. Revenue Cycle Management (RCM) transitioned from stabilization to a core strength, reducing claim rejection rates by over 60% through automation and AI deployment. The Lab Products segment bene ...